Furthermore, MDK treatment enhanced tumorigenesis in vivo and correlated with increased cancer cell proliferation in younger patients with ER-positive breast cancer, which the authors link to sterol regulatory element-binding transcription factor 1 (SREBF1) via PI3K/AKT/mTOR signaling [120]. The gene discussed is AKT1; the disease is cancer.